TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biokjemi Norge AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
28,855
|
23,222
|
20,028 |
| Financial expenses |
228
|
286
|
226 |
| Earnings before taxes |
1,904
|
350
|
-1,864 |
| Total assets |
12,092
|
12,969
|
13,389 |
| Current assets |
9,325
|
10,117
|
10,157 |
| Current liabilities |
5,281
|
7,766
|
8,192 |
| Equity capital |
6,811
|
5,203
|
5,197 |
| - share capital |
97
|
99
|
106 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.3%
|
40.1%
|
38.8% |
| Turnover per employee |
4,809
|
3,870
|
3,338 |
| Profit as a percentage of turnover |
6.6%
|
1.5%
|
-9.3% |
| Return on assets (ROA) |
17.6%
|
4.9%
|
-12.2% |
| Current ratio |
176.6%
|
130.3%
|
124.0% |
| Return on equity (ROE) |
28.0%
|
6.7%
|
-35.9% |
| Change turnover |
6,044
|
4,521
|
-6,339 |
| Change turnover % |
26%
|
24%
|
-24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.